Panmad IV Injection is a potent proton pump inhibitor designed to significantly reduce gastric acid production in the stomach. This medication is primarily utilized in the treatment of various acid-related disorders such as acid reflux, peptic ulcer disease, and Zollinger-Ellison syndrome. The injection form of Panmad IV ensures rapid absorption and effective relief from symptoms like heartburn and stomach discomfort while promoting the healing of ulcers in the gastrointestinal tract. Additionally, healthcare professionals often administer Panmad IV Injection to prevent stress ulcers in critically ill patients, particularly before surgical procedures to minimize the risk of aspiration complications. By targeting the stomach's acid production at its source, Panmad IV supports a faster recovery, making it a key component in the management of acid-related conditions.
Key Features
Features | Description |
---|---|
Type of Medication | Proton Pump Inhibitor (PPI) |
Administration | Intravenous injection |
Primary Uses | Treatment of acid-related stomach and intestinal diseases |
Additional Uses | Prevention of stress ulcers and aspiration-related complications |
Symptom Relief | Reduces heartburn and discomfort effectively |
Healing Support | Promotes healing of peptic ulcers |
Indications | Acid reflux, peptic ulcer disease, Zollinger-Ellison syndrome |
Impact on Acid Production | Significantly decreases stomach acid production |
Attributes | Description |
---|---|
Formulation | Injection for intravenous use |
Dosage | Administered based on medical guidance |
Storage Conditions | Store at controlled room temperature, away from light |
Excipients | Contains stabilizers and preservatives suitable for IV use |
Shelf Life | Check packaging for expiration date |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Incorporation Type
private limited company
GST
24AAPCM5393Q1ZI
Number of Employees
1 To 10 People
Import Export Code (IEC)
AAPCMXXXXX
Nature of Business
manufacturer / distributor / exporter / importer
GlobalLinker Member Since
March 2024
Annual Turnover: INR 5.00 crore - INR 10.00 crore
Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals
Location(s): Rajkot (India)
Medisurge Lifescience Private Limited, owned and operated by Dipak Vagadiya. Our mission is a fast-casual Health and Medical service provider that serves the highest quality health to all the people in the World therefore our aims to expand our work to an International area. We understand that our customers are health-conscious but have busy lives with little time for healthy Life. Our headquarter is in Rajkot, Gujarat and opened in 2018.
Country Of Origin: India
Panmad IV Injection is a medicine that reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine such as acid reflux, peptic ulcer disease, Zollinger-Ellison syndrome. It provides relief from symptoms and promotes healing.
Panmad IV Injection is also used to prevent stress ulcers in seriously ill patients and is administered before anesthetic medication to help prevent aspiration-related complications. It belongs to a class of medicines known as proton pump inhibitors (PPIs).
Rajkot, India
Manufacturer, Distributor, Exporter, Importer, Wholesaler
GST- 24AAPCM5393Q1ZI
FIEO Registered